Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • November 2003 | Volume 16 - Issue 11
    By Lowell Scott Weil, Jr., DPM, MBA; By Patrick A. DeHeer, DPM, with Stephen M. Offutt, DPM, Gary A. Trent, DPM, and Michael J. Baker, DPM
    55,194 reads | 0 comments | 09/03/08
    Hope. Lowell Scott Weil Jr., DPM, says ESWT is a non-invasive alternative with minimal risk for patients who have failed conservative treatment for plantar fasciitis. Medical devices and technology are constantly changing and evolving with the “newest and best” treatments being constantly promoted. Whenever new treatments emerge, they must be looked at carefully and critically to assess their efficacy and safety. They must also be compared to the currently accepted treatments and their benefits over those modalities. Extracorporeal shockwave therapy (ESWT) for the treatment of musculos... continue reading
    Here is a view of a melanoma on the foot. A recent study suggests that individuals diagnosed with melanoma of the foot or ankle have a lower survival rate than those who have melanomas diagnosed elsewhere on the body.
    By Brian McCurdy, Associate Editor
    5,425 reads | 0 comments | 09/03/08
    Compliance may be an issue for diabetic patients wearing removable cast walkers, according to the results of a recent study on activity patterns. A recent study in Diabetes Care assesses the activity patterns of those with diabetic foot ulcerations and finds those involved in the study did not have adequate plantar pressure relief for nearly 75 percent of the steps they were taking. The study tracked 20 patients with neuropathic diabetic foot wounds, which were all classified as University of Texas grade 1 stage A. The patients each received a standard removable cast walker (Royce Me... continue reading
    By Michael Z. Metzger, DPM, MBA
    8,931 reads | 0 comments | 09/03/08
    The office brochure is an effective and comparatively inexpensive method for both internal and external marketing of your practice. With the advent of desktop publishing, almost anyone with a computer and a few hours can design, write and edit the brochure. Once it is printed, you can use the brochure to promote your practice effectively to present and future patients, referring physicians and insurance companies. However, to be successful, you must understand certain concepts such as color, paper weight, font and layout. At one time, an office brochure was considered a tool for only the most... continue reading
    Patients with plantar fasciitis may get a better night’s sleep with the HealWell®Cub™.

    1,766 reads | 0 comments | 09/03/08
    A new philosophy toward skin care now combines the best ingredients of several systems to emphasize prevention. The new Secura™ Skin Care System combines elements of Smith and Nephew’s Triple Care™ and Nursing Care™. As the company notes, the new line combines the already known skin-friendly formulas to emphasize preventive skin care rather than mere basic care. Secura is available in a color-coded system consisting of four steps: cleansing, protecting, moisturizing and treating. It’s part of Smith and Nephew’s new Skin Equity™ ph... continue reading
    It has been shown that using proprioceptive/balance training programs has resulted in a twofold decrease in the risk of recurrent ankle sprain.
    By John Hester, DPM, PT
    10,519 reads | 0 comments | 09/03/08
    Here is an intraoperative view of the GraftJacket, which “supports rapid revascularization and cellular repopulation,” according to the manufacturer.
    By Brian McCurdy, Associate Editor
    7,856 reads | 0 comments | 09/03/08
    Ulcer management and repair is an important aspect of podiatric practice. When it comes to facilitating ulcer treatment, there are regenerative tissue matrices that one may use. Easy application is a must in such products and it’s also important to ensure even healing in the affected area. It’s also an advantage when the graft you select has a number of potential applications. With this in mind, one may want to consider the GraftJacket™ scaffold (Wright Medical), a human dermal membrane that has won raves from podiatrists. GraftJacket’s ease of use and single applicati... continue reading
    The author recommends using a night splint when patients still have pain greater than three (on a pain scale of one to 10) two months after treatment.
    By John Mozena, DPM
    13,208 reads | 0 comments | 09/03/08
    Plantar fasciitis is certainly one of the most common conditions we see in podiatric practice and more than 90 percent of patients are cured with conservative treatment.1 It sounds relatively simple. Well, in order to consistently facilitate successful outcomes, not only must one have a strong anatomical understanding of the plantar fascia, there must also be a strong command of the various causes of the condition, key diagnostic indicators and when to apply various treatment solutions in the armamentarium. ... continue reading
    Here is a close-up view of an ischemic foot with necrotic ulcerations.
    Clinical Editor: Lawrence Karlock, DPM
    9,586 reads | 0 comments | 09/03/08
    Ischemic wounds can be challenging for any physician. With this in mind, the panelists discuss key indicators to look for in the history and physical exam, the effectiveness of noninvasive vascular testing and parameters for performing an amputation after bypass surgery. They also explore the treatment possibilities of angioplasty/stenting and the long leg distal bypass. Without further delay, here is what they had to say. Q: What is your workup/treatment plan when a new patient presents with an ischemic foot wound? A: Mark Beylin, DPM, says it starts by determining the patient’s ... continue reading
    By Jeff Hall, Editor-in-Chief
    2,034 reads | 0 comments | 09/03/08
    When it comes to multicenter clinical trials for various wound care modalities, it stands to reason all the elements of the study should be constant with the key variable being the modality or modalities one is comparing in order to determine the efficacy. However, what if one of those study elements (say offloading) is handled differently by the researchers involved in the study? Wouldn’t that detract from the validity of the results? It’s a significant question raised in a recent Diabetes Care editorial, “Trials In Neuropathic Diabetic Foot Ulceration,” penned by David Arm... continue reading
    By Leon Brill, DPM, CWS
    7,514 reads | 0 comments | 09/03/08
    The research of the ‘70s and ‘80s seems to have paid off in the array of high-tech bioactive wound care products and innovative dressings that have emerged on the market in recent years. We have seen new and improved hydrogels, alginates, growth factors, living skin equivalents and vacuum assisted closure, not to mention new classes of antibiotics to cover emergent drug resistant organisms and modifications of existing antibiotic classes to increase the spectrum of activity. Did I mention silver ion dressings and combination dressings? We have been given an armamentarium unlike we hav... continue reading